Many today are discussing how clinical trials will look differently after the pandemic. Innovative approaches that had been developed in recent years but were stalled in “experimentation” have been rapidly adopted over 2020 as pandemic counter-measures, and many organizations are now making commitments to embed these approaches into their clinical trial pipelines going forward. These …
Continue reading “The “Five Big Shifts” Coming Next to Clinical Trials”